Europe - EPA:BIM - FR0013280286 - Common Stock
We assign a fundamental rating of 6 out of 10 to BIM. BIM was compared to 60 industry peers in the Health Care Equipment & Supplies industry. BIM has an excellent financial health rating, but there are some minor concerns on its profitability. BIM has a correct valuation and a medium growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROIC | 8.55% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.37% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Altman-Z | 6.77 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.88 | ||
| Fwd PE | 21.15 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.98 | ||
| EV/EBITDA | 13.12 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.83% |
EPA:BIM (11/14/2025, 7:00:00 PM)
107.6
-0.7 (-0.65%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.83% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.88 | ||
| Fwd PE | 21.15 | ||
| P/S | 3.09 | ||
| P/FCF | 28.98 | ||
| P/OCF | 16.17 | ||
| P/B | 3.24 | ||
| P/tB | 4.56 | ||
| EV/EBITDA | 13.12 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROCE | 11.69% | ||
| ROIC | 8.55% | ||
| ROICexc | 9.37% | ||
| ROICexgc | 13.09% | ||
| OM | 12.37% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% | ||
| FCFM | 10.66% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Debt/EBITDA | 0.36 | ||
| Cap/Depr | 73.33% | ||
| Cap/Sales | 8.45% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.99% | ||
| Profit Quality | 116.27% | ||
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 6.77 |
ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.
ChartMill assigns a valuation rating of 4 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.
BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.
The Price/Earnings (PE) ratio for BIOMERIEUX (BIM.PA) is 27.88 and the Price/Book (PB) ratio is 3.24.
The dividend rating of BIOMERIEUX (BIM.PA) is 3 / 10 and the dividend payout ratio is 28.08%.